Cargando…
CK19-positive Hepatocellular Carcinoma is a Characteristic Subtype
The heterogeneity of hepatocellular carcinoma (HCC) commonly leads to therapeutic failure of HCC. Cytokeratin 19 (CK19) is well acknowledged as a biliary/progenitor cell marker and a marker of tumor stem cell. CK19-positive HCCs demonstrate aggressive behaviors and poor outcomes which including wors...
Autores principales: | Zhuo, Jian-Yong, Lu, Di, Tan, Win-Yen, Zheng, Shu-Sen, Shen, You-Qing, Xu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378918/ https://www.ncbi.nlm.nih.gov/pubmed/32742454 http://dx.doi.org/10.7150/jca.44697 |
Ejemplares similares
-
CK 20‐positive and CK 7‐negative Merkel cell carcinoma of the cheek
por: Rai, Manoj Ponadka, et al.
Publicado: (2018) -
Immunohistochemiocal subtyping using CK20 and CK5 can identify urothelial carcinomas of the upper urinary tract with a poor prognosis
por: Sikic, Danijel, et al.
Publicado: (2017) -
CK5/6-positive, P63-positive lymphoepithelioma-like hepatocellular carcinoma: A case report and literature review
por: Tang, Hong-Tao, et al.
Publicado: (2023) -
Utility of CK8, CK10, CK13, and CK17 in Differential Diagnostics of Benign Lesions, Laryngeal Dysplasia, and Laryngeal Squamous Cell Carcinoma
por: Boricic, Novica, et al.
Publicado: (2022) -
Impact of immunohistochemistry-based subtyping of GATA3, CK20, CK5/6, and CK14 expression on survival after radical cystectomy for muscle-invasive bladder cancer
por: Bejrananda, Tanan, et al.
Publicado: (2021)